BioCentury
ARTICLE | Company News

Novacta Ltd., Ministry of Defence deal

November 24, 2008 8:00 AM UTC

The ministry will evaluate Novacta's lantibiotics for antiviral use. Novacta's Novacta Therapeutics unit is developing NVB302, a preclinical lantibiotic, to treat Clostridium difficile infection. Fin...